Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2

View ORCID ProfileB Korber, View ORCID ProfileWM Fischer, View ORCID ProfileS Gnanakaran, H Yoon, View ORCID ProfileJ Theiler, W Abfalterer, View ORCID ProfileB Foley, EE Giorgi, View ORCID ProfileT Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman, View ORCID ProfileTI de Silva, on behalf of the Sheffield COVID-19 Genomics Group, View ORCID ProfileCC LaBranche, View ORCID ProfileDC Montefiori
doi: https://doi.org/10.1101/2020.04.29.069054
B Korber
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for B Korber
  • For correspondence: btk@lanl.gov
WM Fischer
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for WM Fischer
S Gnanakaran
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S Gnanakaran
H Yoon
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Theiler
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Theiler
W Abfalterer
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Foley
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for B Foley
EE Giorgi
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Bhattacharya
1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T Bhattacharya
MD Parker
3Sheffield Biomedical Research Centre & Sheffield Bioinformatics Core, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DG Partridge
4Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CM Evans
4Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TM Freeman
3Sheffield Biomedical Research Centre & Sheffield Bioinformatics Core, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TI de Silva
4Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
5Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for TI de Silva
CC LaBranche
2Duke Human Vaccine Institute & Department of Surgery, Durham, North Carolina, 27710 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for CC LaBranche
DC Montefiori
2Duke Human Vaccine Institute & Department of Surgery, Durham, North Carolina, 27710 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for DC Montefiori
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics. To date we have identified thirteen mutations in Spike that are accumulating. Mutations are considered in a broader phylogenetic context, geographically, and over time, to provide an early warning system to reveal mutations that may confer selective advantages in transmission or resistance to interventions. Each one is evaluated for evidence of positive selection, and the implications of the mutation are explored through structural modeling. The mutation Spike D614G is of urgent concern; it began spreading in Europe in early February, and when introduced to new regions it rapidly becomes the dominant form. Also, we present evidence of recombination between locally circulating strains, indicative of multiple strain infections. These finding have important implications for SARS-CoV-2 transmission, pathogenesis and immune interventions.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • This Version (2) corrects analysis that was based on the codon encoding Spike position 943; the apparent mutation at 943 was the result of a sequence error. The main conclusions of the paper regarding the mutation in Spike at 614 and recombination still hold. The key difference in version 2 is that we have removed the original figure 6, which was based on the 943 sequencing artifact, and instead moved a figure illustrating recombination that was independent of position 943 from the supplement into the main text. BK

  • ↵# Members of Sheffield COVID-19 Genomics Group: Adrienne Angyal, Rebecca L. Brown, Laura Carrilero, Luke R. Green, Danielle C. Groves, Katie J Johnson, Alexander J Keeley, Benjamin B Lindsey, Paul J Parsons, Mohammad Raza, Sarah Rowland-Jones, Nikki Smith, Rachel M. Tucker, Dennis Wang, Matthew D. Wyles

  • This Version (2) corrects analysis that was based on the codon encoding Spike position 943; the apparent mutation at 943 was the result of a sequence error. The main conclusions of the paper regarding the mutation in Spike at 614 and recombination still hold. The key difference in version 2 is that we have removed the original figure 6, which was based on the 943 sequencing artifact, and instead moved a figure illustrating recombination that was independent of position 943 from the supplement into the main text.

  • https://www.gisaid.org

  • https://COV.lanl.gov

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, B Foley, EE Giorgi, T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman, TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group, CC LaBranche, DC Montefiori
bioRxiv 2020.04.29.069054; doi: https://doi.org/10.1101/2020.04.29.069054
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, B Foley, EE Giorgi, T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman, TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group, CC LaBranche, DC Montefiori
bioRxiv 2020.04.29.069054; doi: https://doi.org/10.1101/2020.04.29.069054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Evolutionary Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4241)
  • Biochemistry (9173)
  • Bioengineering (6806)
  • Bioinformatics (24064)
  • Biophysics (12155)
  • Cancer Biology (9565)
  • Cell Biology (13825)
  • Clinical Trials (138)
  • Developmental Biology (7658)
  • Ecology (11737)
  • Epidemiology (2066)
  • Evolutionary Biology (15543)
  • Genetics (10672)
  • Genomics (14360)
  • Immunology (9512)
  • Microbiology (22903)
  • Molecular Biology (9129)
  • Neuroscience (49115)
  • Paleontology (357)
  • Pathology (1487)
  • Pharmacology and Toxicology (2583)
  • Physiology (3851)
  • Plant Biology (8351)
  • Scientific Communication and Education (1473)
  • Synthetic Biology (2301)
  • Systems Biology (6205)
  • Zoology (1302)